Indeed, preclinical studies on murine models of brain metastases have shown that systemic administration of TNF can permeabilize the BBTB to the anti-human epidermal growth factor receptor (HER) 2 mAb trastuzumab at tumor sites [72]. Here, TNF is linked to neoplasm.